# Waters Corporation (WAT) financials

Waters Corporation reported revenue of $3.17 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 7.0% from fiscal 2024. Net income was $643 million and diluted earnings per share $10.76.

In its latest reported quarter, the third quarter of fiscal 2026 (the three months to 3 Oct 2026), revenue was $1.77 billion, up 121% from a year earlier.

Source: Waters Corporation's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 10 Nov 2026. Amounts in USD. Page: https://aapwire.com/stocks/WAT. Retrieved 2026-11-16.

## Latest results: Q3 FY2026

Waters Corporation reported revenue of $1.77 billion, up 121% from a year earlier, net income of $81.0 million and diluted earnings per share of $0.82 against $2.50 for the third quarter of fiscal 2026 (the three months to 3 Oct 2026).

From its quarterly report, the results first announced on 3 Nov 2026.

| Measure | Q3 FY2026 | Q3 FY2025 | Change |
| --- | ---: | ---: | ---: |
| Revenue | $1.77B | $800.0M | +121% |
| Operating income | $128.0M | $192.0M | −33.3% |
| Operating margin | 7.2% | 24.0% | −16.8 pts |
| Net income | $81.00M | $149.0M | −45.6% |
| Diluted EPS | $0.82 | $2.50 | −67.2% |
| Operating cash flow | $117.0M | $187.0M | −37.4% |
| Capital expenditure | $63.00M | $25.00M | +152% |
| Free cash flow | $54.00M | $162.0M | −66.7% |

Page: https://aapwire.com/stocks/WAT/earnings

## Annual figures (fiscal years)

| Measure | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $2.17B | $2.31B | $2.42B | $2.41B | $2.37B | $2.79B | $2.97B | $2.96B | $2.96B | $3.17B |
| Revenue growth | +6.1% | +6.5% | +4.8% | −0.6% | −1.7% | +17.8% | +6.7% | −0.5% | +0.1% | +7.0% |
| Gross profit | $1.28B | $1.36B | $1.43B | $1.40B | $1.36B | $1.63B | $1.72B | $1.76B | $1.76B | $1.88B |
| Operating income | $625.0M | $662.2M | $739.8M | $708.5M | $645.5M | $821.7M | $873.4M | $817.7M | $826.4M | $802.6M |
| Net income | $521.5M | $20.31M | $593.8M | $592.2M | $521.6M | $692.8M | $707.8M | $642.2M | $637.8M | $642.6M |
| Diluted EPS | $6.41 | $0.25 | $7.65 | $8.69 | $8.36 | $11.17 | $11.73 | $10.84 | $10.71 | $10.76 |
| Operating cash flow | $642.9M | $697.6M | $604.4M | $643.1M | $790.5M | $747.3M | $611.7M | $602.8M | $762.1M | $652.6M |
| Capital expenditure | $94.97M | $85.47M | $96.08M | $163.8M | $172.4M | $161.3M | $175.9M | $160.6M | $142.5M | $112.7M |
| Free cash flow | $548.0M | $612.2M | $508.4M | $479.3M | $618.1M | $586.0M | $435.7M | $442.2M | $619.6M | $539.8M |
| Gross margin | 58.9% | 59.0% | 59.0% | 58.0% | 57.4% | 58.5% | 58.0% | 59.6% | 59.4% | 59.3% |
| Operating margin | 28.8% | 28.7% | 30.6% | 29.4% | 27.3% | 29.5% | 29.4% | 27.7% | 27.9% | 25.4% |
| Net margin | 24.1% | 0.9% | 24.5% | 24.6% | 22.1% | 24.9% | 23.8% | 21.7% | 21.6% | 20.3% |
| Cash and equivalents | $505.6M | $642.3M | $796.3M | $335.7M | $436.7M | $501.2M | $480.5M | $395.1M | $325.4M | $588.0M |
| Total debt | $1.83B | $2.00B | $1.15B | $1.78B | $1.45B | $1.60B | $1.66B | $2.44B | $1.70B | $1.49B |
| Shareholders' equity | $2.30B | $2.23B | $1.57B | −$216.3M | $232.1M | $367.6M | $504.5M | $1.15B | $1.83B | $2.56B |
| Diluted shares | 81.4M | 80.6M | 77.6M | 68.2M | 62.4M | 62.0M | 60.3M | 59.3M | 59.6M | 59.7M |

## Quarterly figures (last eight fiscal quarters)

| Measure | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $872.7M | $662.0M | $771.0M | $800.0M | $932.4M | $1.27B | $1.65B | $1.77B |
| Revenue, year on year | +6.5% | +4.0% | +8.8% | +8.1% | +6.8% | +91.4% | +113% | +121% |
| Gross margin | 60.1% | — | — | — | 61.1% | — | — | — |
| Operating income | $292.3M | $152.0M | $188.0M | $192.0M | $270.5M | −$47.00M | −$86.00M | $128.0M |
| Net income | $231.4M | $121.0M | $147.0M | $149.0M | $225.6M | −$72.00M | −$136.0M | $81.00M |
| Diluted EPS | $3.88 | $2.03 | $2.47 | $2.50 | $3.77 | −$0.87 | −$1.39 | $0.82 |
| Free cash flow | $188.0M | $234.0M | $18.00M | $162.0M | $125.8M | −$42.00M | $153.0M | $54.00M |

## Operating KPIs

| KPI | Latest | Period | Change on a year |
| --- | ---: | --- | --- |
| [Consumables revenue](https://aapwire.com/stocks/WAT/kpi/consumables-revenue) | $806.0M | quarter to 3 Oct 2026 | up 410.1% |
| [Waters Instrument Systems revenue](https://aapwire.com/stocks/WAT/kpi/waters-instrument-systems-revenue) | $354.7M | quarter to 31 Dec 2025 | up 4.1% |
| [Waters Service revenue](https://aapwire.com/stocks/WAT/kpi/waters-service-revenue) | $298.9M | quarter to 31 Dec 2025 | up 9.7% |
| [TA Instrument Systems revenue](https://aapwire.com/stocks/WAT/kpi/ta-instrument-systems-revenue) | $78.1M | quarter to 31 Dec 2025 | down 1.0% |
| [TA Service revenue](https://aapwire.com/stocks/WAT/kpi/ta-service-revenue) | $30.3M | quarter to 31 Dec 2025 | up 2.6% |
| [Waters Analytical & Material Sciences revenue](https://aapwire.com/stocks/WAT/kpi/waters-analytical-and-material-sciences-revenue) | $796.0M | quarter to 3 Oct 2026 | up 8.2% |
| [Waters Advanced Diagnostics revenue](https://aapwire.com/stocks/WAT/kpi/waters-advanced-diagnostics-revenue) | $575.0M | quarter to 3 Oct 2026 | up 798.4% |
| [Waters Biosciences revenue](https://aapwire.com/stocks/WAT/kpi/waters-biosciences-revenue) | $396.0M | quarter to 3 Oct 2026 | — |
| [United States revenue](https://aapwire.com/stocks/WAT/kpi/united-states-revenue) | $621.0M | quarter to 3 Oct 2026 | up 153.5% |
| [European Union revenue](https://aapwire.com/stocks/WAT/kpi/european-union-revenue) | $523.0M | quarter to 3 Oct 2026 | up 120.7% |
| [Asia Other revenue](https://aapwire.com/stocks/WAT/kpi/asia-other-revenue) | $269.0M | quarter to 3 Oct 2026 | up 72.4% |
| [China revenue](https://aapwire.com/stocks/WAT/kpi/china-revenue) | $226.0M | quarter to 3 Oct 2026 | up 98.2% |
| [Americas Other revenue](https://aapwire.com/stocks/WAT/kpi/americas-other-revenue) | $128.0M | quarter to 3 Oct 2026 | up 166.7% |

## Method

Each period is read from the report the company filed and checked against accounting identities; a figure that does not pass is left blank (—), never estimated. Free cash flow is operating cash flow less capital expenditure. Diluted EPS is as the company reported it, adjusted for later stock splits. Research information only, not investment advice.
